These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6538517)

  • 1. The value of prolactin dynamics as a predictor of ovulation with bromocriptine in patients with polycystic ovary syndrome.
    Mattox JH; Buckman MT; Peake GT
    Fertil Steril; 1984 Apr; 41(4):569-74. PubMed ID: 6538517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome.
    Ferriani RA; Silva de Sá MF; Moura MD; Moreira AC; Gomes UA
    Gynecol Endocrinol; 1989 Dec; 3(4):317-27. PubMed ID: 2516707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction with bromocriptine in normoprolactinemic anovulatory women.
    Suginami H; Hamada K; Yano K; Kuroda G; Matsuura S
    J Clin Endocrinol Metab; 1986 May; 62(5):899-903. PubMed ID: 3958126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanism of induction of ovulation by bromocriptine in euprolactinemic anovulation--the role of occult hyperprolactinemia in anovulation].
    Mori H; Aisaka K; Matsuoka R; Kigawa T
    Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):38-47. PubMed ID: 3996685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined therapy with bromocriptine, clomiphene and gonadotropin for polycystic ovary syndrome patients failing to respond to clomiphene alone].
    Kubota T; Kamada S; Oiyama H; Tsuzuki H; Nishi N; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):323-30. PubMed ID: 2966223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of prolactin-secreting-capacity to circadian profile of prolactin in euprolactinemic women with ovulatory disturbances].
    Mori H; Aisaka K; Matsuoka R; Kigawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):287-92. PubMed ID: 3919123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine in polycystic ovarian disease: a controlled clinical trial.
    el Tabbakh GH; Loutfi IA; Azab I; Rahman HA; Southren AL; Aleem FA
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):301-6. PubMed ID: 3279350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine].
    Suginami H; Ito T; Hamada K; Yano K; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):728-34. PubMed ID: 3722953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of prolactin secretion in polycystic ovary syndrome.
    Murdoch AP; Dunlop W; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):165-75. PubMed ID: 3085993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
    Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
    Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome and hyperprolactinemia.
    Bracero N; Zacur HA
    Obstet Gynecol Clin North Am; 2001 Mar; 28(1):77-84. PubMed ID: 11293005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of polycystic ovary induction to prolactin secretion: prevention of cyst formation by bromocriptine in the rat.
    Copmann TL; Adams WC
    Endocrinology; 1981 Mar; 108(3):1095-7. PubMed ID: 7460836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.